Skip to main content

Adcock Ingram Holdings Limited (AIP.JO)

JNB Healthcare Drug Manufacturers - Specialty & GenericView data quality →
57.9Fair

ValueMarkers Composite Index

Top 71%#13,014 of 44,714
Undervalued

39% below intrinsic value ($698)

UndervaluedFair ValueOvervalued
Piotroski
5/9
Neutral
Beneish
-2.36
Low Risk
Altman
5.14
Safe
DCF Value
$698
Undervalued
ROIC
13.8%
Adequate
P/E
12.8
Value
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Adcock Ingram Holdings Limited (AIP.JO) — VMCI valuation read

The headline on Adcock Ingram Holdings Limited (AIP.JO) is a 58/100 VMCI score, set against a Healthcare sector median of 50. That 8-point above-median read reflects the five-pillar weighting and, for a mid-cap name, suggests a relative-value tailwind is in the data.

AIP.JO insider activity report: 0 buys, 0 sells filed via Form 4 over the past 30 days. The next datable items are the 10-Q schedule and any 8-K-triggering events; both feed the VMCI Integrity pillar more than the price tape.

**Investor frame.** AIP.JO trades at 19.0x earnings, 6% above the Healthcare median of 18.0x sets the value side. ROIC of 19.0% sits 9.0pp above the Healthcare median (10.0%) sets the quality side. Net debt to EBITDA of -2.2x leaves covenant headroom sets the risk side, the three lines a value buyer reads first on AIP.JO.

AIP.JO rose 3.5% over the trailing 7 days, with a -22.2% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in AIP.JO’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.